IPCALAB
PharmaceuticalsIpca Laboratories Ltd.
NSE: IPCALABBSE: 524494ISIN: INE571A01020
₹1,968.50
-2.40 · -0.12%
As of 11 Sept 2026
Open
₹1,975.80
High
₹1,995.00
Low
₹1,958.40
Prev Close
₹1,970.90
52W High
₹2,001.50
52W Low
₹1,251.60
Volume
1.76 L
Mkt Cap
₹49,912 Cr
Fundamentals
Valuation & profitability
Market Cap
₹49,912 Cr
P/E Ratio
55.3
EPS (TTM)
₹35.60
Book Value
₹250.00
Dividend Yield
0.32%
ROCE
12.8%
ROE
9.35%
Sales Growth
12%
Face Value
₹1.00
Key highlights
Auto-generated from live data
- Trades at a P/E of 55.3, with a return on equity (ROE) of 9.35%.
- IPCALAB is trading above all of its key moving averages (10/20/50/100/200-DMA) — a bullish technical setup.
- Year-to-date it is up 41.68%, and up 41.38% over the past year.
- At ₹1,968.50 it sits about 96% of the way up its 52-week range (₹1,251.60–₹2,001.50).
- Offers a dividend yield of 0.32%.
- Market capitalisation stands at ₹49,912 Cr.
Price chart
Daily candles + volume · SMA 20 / 50 / 200 · stored OHLC
Shareholding pattern
Shareholding data syncs daily.
Performance
Stock returns vs Nifty 50
10D
+1.11%
Nifty -1.98%
20D
+3.84%
Nifty -2.76%
50D
+11.95%
Nifty -1.38%
100D
+31.47%
Nifty +1.41%
200D
+34.53%
Nifty -8.32%
YTD
+41.68%
Nifty -10.09%
52W
+41.38%
Nifty -10.42%
Moving averages
Simple moving averages vs current price
SMA 10-Day
₹1,966.97Above
SMA 20-Day
₹1,943.14Above
SMA 50-Day
₹1,845.72Above
SMA 100-Day
₹1,716.54Above
SMA 200-Day
₹1,594.79Above
Price ranges
Where the price sits in each window
10-Day range₹1,968.50
₹1,907.90₹2,001.50
20-Day range₹1,968.50
₹1,805.90₹2,001.50
50-Day range₹1,968.50
₹1,674.40₹2,001.50
200-Day range₹1,968.50
₹1,361.70₹2,001.50
YTD range₹1,968.50
₹1,391.10₹2,001.50
52-Week range₹1,968.50
₹1,251.60₹2,001.50
Technical signals
Unfilled gaps acting as support / resistance
Unfilled Gap Up On 17 Aug, 2026 : 1805.90 ~ 1805.00SUPPORT
Unfilled Gap Up On 23 Oct, 2023 : 958.05 ~ 949.85SUPPORT
Unfilled Gap Down On 10 Jan, 2022 : 1128.50 ~ 2137.40RESISTANCE
Annual financials
Revenue, profit & EPS by financial year
| Year | Revenue | Net Profit | EPS | NPM |
|---|---|---|---|---|
| Mar 2023 | ₹5,815 Cr | ₹506 Cr | ₹19.93 | 8.7% |
| Mar 2022 | ₹5,399 Cr | ₹871 Cr | ₹34.33 | 16.13% |
| Mar 2021 | ₹5,395 Cr | ₹1,140 Cr | ₹89.87 | 21.13% |
| Mar 2021 | ₹5,395 Cr | ₹1,140 Cr | ₹89.87 | 21.13% |
| Mar 2020 | ₹4,619 Cr | ₹606 Cr | ₹47.99 | 13.12% |
| Mar 2020 | ₹4,619 Cr | ₹606 Cr | ₹47.99 | 13.12% |
| Mar 2019 | ₹3,746 Cr | ₹445 Cr | ₹35.21 | 11.88% |
| Mar 2019 | ₹3,746 Cr | ₹445 Cr | ₹35.21 | 11.88% |
| Mar 2018 | ₹3,258 Cr | ₹239 Cr | ₹18.97 | 7.34% |
| Mar 2017 | ₹3,156 Cr | ₹195 Cr | ₹15.42 | 6.18% |
| Mar 2016 | ₹2,867 Cr | ₹93 Cr | ₹7.38 | 3.24% |
| Mar 2015 | ₹3,144 Cr | ₹254 Cr | ₹20.15 | 8.08% |
Peer comparison
Other companies in Pharmaceuticals
| Company | P/E | Book Value | Sales Growth |
|---|---|---|---|
| SUNPHARMA SUN PHARMACEUTICAL INDUSTRIES LTD. | 39.1 | ₹98.33 | 10.1% |
| MARKSANS MARKSANS PHARMA LTD. | 23.8 | ₹11.85 | 5.8% |
| MOREPENLAB MOREPEN LABORATORIES LTD. | 20.81 | ₹6.43 | 16.6% |
| NEULANDLAB NEULAND LABORATORIES LTD. | 23.48 | ₹542.16 | 9.35% |
| GUFICBIO Gufic BioSciences Ltd. | 24.16 | ₹10.85 | 20.41% |
| DIVISLAB DIVI'S LABORATORIES LTD. | 41.01 | ₹266.77 | 9.47% |
| DRREDDY DR.REDDY'S LABORATORIES LTD. | 19.73 | ₹852.69 | 1.07% |
| RPGLIFE RPG LIFE SCIENCES LTD. | 17.14 | ₹105.02 | 5.73% |
| GLAND Gland Pharma Ltd | 53.6 | ₹242.00 | — |
| ZYDUSLIFE Zydus Lifesciences Ltd | 8.23 | ₹166.00 | 5% |
| SMSPHARMA SMS PHARMACEUTICALS LTD. | 9.58 | ₹42.07 | -8.73% |
| CIPLA CIPLA LTD. | 15.36 | ₹209.71 | 0.7% |
Dividend history
Per share, by ex-date
Ex-Date: 07 Feb 2022₹0.05
Ex-Date: 15 Sept 2021₹0.05
Ex-Date: 13 Nov 2020₹8.00
Ex-Date: 18 Feb 2020₹5.00
Ex-Date: 07 Nov 2019₹0.10
Ex-Date: 06 Aug 2019₹3.00
Ex-Date: 19 Sept 2018₹0.10
Ex-Date: 02 Aug 2018₹1.00
Ex-Date: 26 Feb 2018₹0.10
Ex-Date: 27 Jul 2017₹1.00
Ex-Date: 22 Jul 2015₹1.00
Ex-Date: 18 Jul 2014₹2.50
Bulk & block deals
Recent large transactions
| Date | Client | Type | Qty | Price |
|---|---|---|---|---|
| 25 Mar 2021 | L7 HITECH PRIVATE LIMITED | SALE | 69,99,573 | ₹46.09 |
| 25 Mar 2021 | RAVI OMPRAKASH AGRAWAL | PURCHASE | 70,00,000 | ₹46.09 |
| 24 Mar 2021 | L7 HITECH PRIVATE LIMITED | SALE | 99,62,244 | ₹47.25 |
| 24 Mar 2021 | RAVI OMPRAKASH AGRAWAL | PURCHASE | 1,10,00,000 | ₹47.30 |
| 23 Mar 2021 | AMITA RAVI AGRAWAL | PURCHASE | 50,00,000 | ₹44.35 |
| 23 Mar 2021 | L7 HITECH PRIVATE LIMITED | SALE | 1,00,00,000 | ₹44.00 |
| 23 Mar 2021 | RAVI OMPRAKASH AGRAWAL | PURCHASE | 50,00,000 | ₹43.65 |
| 22 Mar 2021 | AMITA RAVI AGRAWAL | PURCHASE | 50,00,000 | ₹42.35 |
| 22 Mar 2021 | L7 HITECH PRIVATE LIMITED | SALE | 99,60,994 | ₹41.89 |
| 22 Mar 2021 | RAVI OMPRAKASH AGRAWAL | PURCHASE | 49,87,007 | ₹41.44 |
| 19 Mar 2021 | L7 HITECH PRIVATE LIMITED | SALE | 54,89,298 | ₹44.29 |
| 19 Mar 2021 | RAVI OMPRAKASH AGRAWAL | PURCHASE | 55,00,000 | ₹44.29 |
Fundamentals, financials & technicals sourced from niftytrader.in, cached and refreshed periodically.